- What other names is Marshmallow known by?
- What is Marshmallow?
- How does Marshmallow work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Marshmallow.
Altea, Alteia, Althaea officinalis, Althaea taurinensis, Althaeae Folium, Althaeae Radi, Althea, Althée, Guimauve, Guimauve Officinale, Gulkhairo, Herba Malvae, Mallards, Malvavisco, Marsh Maillo, Mauve Blanche, Mortification Root, Racine de Guimauve, Sweet Weed, Wymote.
Marshmallow is a plant. The leaves and the root are used to make medicine. Don't confuse marshmallow with the mallow (Malva sylvestris) flower and leaf.
Marshmallow leaf and root are used for pain and swelling (inflammation) of the mucous membranes that line the respiratory tract. They are also used for dry cough, inflammation of the lining of the stomach, diarrhea, stomach ulcers, constipation, urinary tract inflammation, and stones in the urinary tract.
Marshmallow leaf is used topically as a poultice for insect bites.
Marshmallow root is applied to the skin as an ingredient in ointments for chapped skin as well as for pain and swelling of the feet and hands due to exposure to the cold (chilblains).
In foods, marshmallow leaf and root are used as a flavoring agent.
Insufficient Evidence to Rate Effectiveness for...
- Cough caused by ACE inhibitors. Medications used for high blood pressure called ACE inhibitors can sometimes cause coughing as a side effect. Early research suggests that taking marshmallow root by mouth for 4 weeks can reduce cough caused by ACE inhibitors. Some examples of ACE-inhibitors include captopril (Capoten), enalapril (Vasotec), and lisinopril (Prinivil, Zestril).
- Skin infection caused by parasites (Leishmania lesions). Early research suggests that applying a combination of marshmallow and hollyhock extracts to affected skin for 5 days can help improve Leishmania lesions.
- Skin inflammation.
- Insect bites.
- Chapped skin.
- Stomach and intestinal ulcers.
- Irritation of the mouth and throat.
- Dry cough.
- Other conditions.
Marshmallow forms a protective layer on the skin and lining of the digestive tract. It also contains chemicals that might decrease cough and help heal wounds.
Marshmallow is LIKELY SAFE for most people when taken by mouth. In some people, it might cause low blood sugar levels.
Marshmallow is POSSIBLY SAFE when applied directly to the skin.
Special Precautions & Warnings:Pregnancy and breast-feeding: Not enough is known about the use of marshmallow during pregnancy and breast-feeding. Stay on the safe side and avoid use.
Surgery: Marshmallow might affect blood sugar levels. There is a concern that it could interfere with blood sugar control during and after surgical procedures. Stop taking marshmallow at least 2 weeks before a scheduled surgery.
LithiumInteraction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Marshmallow might have an effect like a water pill or "diuretic." Taking marshmallow might decrease how well the body gets rid of lithium. This could increase how much lithium is in the body and result in serious side effects. Talk with your healthcare provider before using this product if you are taking lithium. Your lithium dose might need to be changed.
Medications for diabetes (Antidiabetes drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Marshmallow might decrease blood sugar. Diabetes medications are also used to lower blood sugar. Taking marshmallow along with diabetes medications might cause your blood sugar to go too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.
Some medications used for diabetes include glimepiride (Amaryl), glyburide (Diabeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
Medications taken by mouth (Oral drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Marshmallow contains a type of soft fiber called mucilage. Mucilage can decrease how much medicine the body absorbs. Taking marshmallow at the same time you take medications by mouth can decrease the effectiveness of your medication. To prevent this interaction, take marshmallow at least one hour after medications you take by mouth.
The appropriate dose of marshmallow for use as treatment depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for marshmallow. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
Beaune, A. and Balea, T. [Anti-inflammatory experimental properties of marshmallow: its potentiating action on the local effects of corticoids]. Therapie 1966;21(2):341-347. View abstract.
Bone K. Marshmallow soothes cough. Br J Phytother 1993;3(2):93.
Cravotto, G., Boffa, L., Genzini, L., and Garella, D. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther 2010;35(1):11-48. View abstract.
Franz G. Die Schleimpolysaccharide von Althaea officinalis und Malva sylvestris. Planta Med 1966;14:90-110.
Franz, G. and Chladek, M. [Comparative studies on the composition of crude mucus from crossbred descendants of Althaea officinalis L. and Althaea armeniaca Ten]. Pharmazie 1973;28(2):128-129. View abstract.
Gudej J. Flavonoids, phenolic acids and coumarins from the roots of Althaea officinalis. Planta Med 1991;57:284-285.
Huriez, C. and Fagez, C. [An association of marshmallow-dexamethasone: the pommade Dexalta]. Lille.Med 1968;13(2):121-123. View abstract.
Meyer E. Behandlung akuter und chronischer Bronchitiden mit Heilpflanzen. Therapiewoche 1956;6:537-540.
Muller-Limmroth, W. and Frohlich, H. H. [Effect of various phytotherapeutic expectorants on mucociliary transport]. Fortschr Med 1-24-1980;98(3):95-101. View abstract.
Nosal'ova, G., Strapkova, A., Kardosova, A., Capek, P., Zathurecky, L., and Bukovska, E. [Antitussive action of extracts and polysaccharides of marsh mallow (Althea officinalis L., var. robusta)]. Pharmazie 1992;47(3):224-226. View abstract.
Piovano, P. B. and Mazzocchi, S. [Clinical trial of a steroid derivative (9-alpha-fluoro-prednisolone-21- acetate) in association with aqueous extract of althea in the dermatological field]. G Ital Dermatol.Minerva Dermatol. 1970;45(4):279-286. View abstract.
Recio MC and et al. Antimicrobial activity of selected plants employed in the Spanish Mediterranean area, Part II. Phytother Res 1989;3:77-80.
Rouhi, H Ganji F. Effect of Althaea officinalis on cough associated with ACE inhibitors. Pakistan Journal of Nutrition 2007;6:256-258.
Scheffer J and König W. Einfluss von Radix althaeae und Flores chamomillae Extrakten auf Entzündungsreaktionen humaner neutrophiler Granulozyten, Monozyten und Rattenmastzellen. Abstracts of 3rd Phytotherapie-Kongress 1991;Abstract P9.
Tomoda, M., Shimizu, N., Oshima, Y., Takahashi, M., Murakami, M., and Hikino, H. Hypoglycemic activity of twenty plant mucilages and three modified products. Planta Med 1987;53(1):8-12. View abstract.
Zerehsaz, F., Salmanpour, R., Handijani, F., Ardehali, S., Panjehshahin, M. R., Tabei, S. Z., and Tabatabaee, H. R. A double-blind randomized clinical trial of a topical herbal extract (Z- HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. Int J Dermatol 1999;38(8):610-612. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182